newsfilter
← Latest News
GlobeNewswire·

AVEO Oncology Announces Participation at Investor Conferences in September

BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that members of